ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

N4P N4 Pharma Plc

0.80
-0.025 (-3.03%)
Last Updated: 10:33:59
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.025 -3.03% 0.80 0.75 0.85 0.825 0.80 0.825 516,619 10:33:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.40 1.45M

N4 Pharma PLC Director/PDMR Shareholding (2255W)

10/11/2017 4:04pm

UK Regulatory


N4 Pharma (LSE:N4P)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more N4 Pharma Charts.

TIDMN4P

RNS Number : 2255W

N4 Pharma PLC

10 November 2017

10(th) November 2017

N4 Pharma plc (the "Company")

Notification of Transaction by Directors/PDMRs

The Company was notified on 10(th) November 2017 that a Person Discharging Management Responsibilities ("PDMR"), had purchased shares in the Company as set out below. Following this purchase, Nigel Theobald now has a total beneficial interest in 12,255,233 Ordinary Shares, representing 16.4% of the issued share capital of the Company.

The Company's share capital consists of 74,714,285 Ordinary Shares with voting rights.

 
 1      Details of the person discharging managerial 
         responsibilities/person closely associated 
-----  -------------------------------------------------------------- 
  a)     Name                           Nigel Theobald 
-----  -----------------------------  ------------------------------- 
 2      Reason for the notification 
-----  -------------------------------------------------------------- 
  a)     Position/status               CEO and Director 
-----  -----------------------------  ------------------------------- 
  b)     Initial notification/         Initial notification 
          Amendment 
-----  -----------------------------  ------------------------------- 
 3      Details of the issuer, emission allowance market 
         participant, auction platform, auctioneer or 
         auction monitor 
-----  -------------------------------------------------------------- 
  a)     Name                          N4 Pharma Plc 
-----  -----------------------------  ------------------------------- 
  b)     LEI                           213800I841D2RKMFK955 
-----  -----------------------------  ------------------------------- 
 4      Details of the transaction(s): section to be 
         repeated for (i) each type of instrument; (ii) 
         each type of transaction; (iii) each date; 
         and (iv) each place where transactions have 
         been conducted 
-----  -------------------------------------------------------------- 
  a)     Description                   Oridinary shares BGP 0.0004 
          of the financial              ISIN code GB00BYW8QM32 
          instrument, 
          type of instrument 
          Identification 
          code 
-----  -----------------------------  ------------------------------- 
  b)     Nature of the                 Direct purchase of shares 
          transaction 
-----  -----------------------------  ------------------------------- 
 c)     Price(s) and                         Price           volume 
         volume(s) 
-----  -----------------------------  -------------------  ---------- 
                         GBP0.07925                          56,656 
  -------------------------------------------------------  ---------- 
 d)     Aggregated                     n/a 
         information 
         - Aggregated 
         price 
         - Aggregated 
         volume 
         - Aggregated 
         total 
-----  -----------------------------  ------------------------------- 
  e)     Date of the                   10(th) November 2017 
          transaction 
-----  -----------------------------  ------------------------------- 
  f)     Place of the                  London Stock Exchange, AIM 
          transaction 
-----  -----------------------------  ------------------------------- 
 g)     Additional 
         Information 
-----  --------------------------------------------------  ---------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEAKFEFEDXFFF

(END) Dow Jones Newswires

November 10, 2017 11:04 ET (16:04 GMT)

1 Year N4 Pharma Chart

1 Year N4 Pharma Chart

1 Month N4 Pharma Chart

1 Month N4 Pharma Chart

Your Recent History

Delayed Upgrade Clock